{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-002241","form_type":"8-K","ticker":"CBIO","cik":"0001253689","company_name":"CRESCENT BIOPHARMA, INC.","filed_at":"2024-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.622450+00:00","generated_at":"2026-06-05T05:18:50.761839+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"GlycoMimetics files 8-K with corporate presentation; no material updates disclosed","bullets":["Filing includes a slide presentation for anticipated investor meetings, March 2024.","Presentation focuses on GlycoMimetics' glycobiology-based therapeutic platform.","No specific financial results, pipeline updates, or guidance changes provided in the filing.","The presentation contains forward-looking statements and standard disclaimers.","No new agreements, regulatory decisions, or material events were announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-002241","json":"https://secwatch.observer/filing/0001558370-24-002241.json","markdown":"https://secwatch.observer/filing/0001558370-24-002241.md","text":"https://secwatch.observer/filing/0001558370-24-002241.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1253689/000155837024002241/0001558370-24-002241-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1253689/000155837024002241/glyc-20240301x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T05:18:50.761839+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}